Drugs / Descartes 30
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04524962 | Feb 2021 → Sep 2022 | COVID-19, acute respiratory distress syndrome | Cartesian Therapeutics | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Descartes 30 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04524962 ↗ |